Medpace Holdings, Inc.
MEDP
Rang in aandelen
#1305
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aandeelprijs
$622.03
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$17.36B
Verandering (1 dag)
0.38%
Verandering (1 jaar)
14.00%
Land
US
Handel Medpace Holdings, Inc. (MEDP)
Categorie
Healthcare
Winst voor Medpace Holdings, Inc. (MEDP)
Winst in Jun 2026 TTM: $598.92M
Volgens de meest recente financiële verslagen van Medpace Holdings, Inc. bedraagt de huidige winst van het bedrijf $598.92M. In 2024 behaalde het bedrijf een winst van $475.92M, een stijging ten opzichte van de winst van 2023, die $335.68M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Medpace Holdings, Inc. van 2013 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $598.92M | 10.43% |
| 2025 | $542.38M | 13.96% |
| 2024 | $475.92M | 41.78% |
| 2023 | $335.68M | 18.67% |
| 2022 | $282.86M | 40.13% |
| 2021 | $201.85M | 19.77% |
| 2020 | $168.53M | 35.01% |
| 2019 | $124.83M | 32.87% |
| 2018 | $93.95M | 64.99% |
| 2017 | $56.95M | 159.35% |
| 2016 | $21.96M | -380.42% |
| 2015 | $-7.83M | -63.17% |
| 2014 | $-21.26M | -154.31% |
| 2013 | $39.15M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | 1,170.45% |
US
|
|
| $4.76B | 695.09% |
US
|
|
| $-252.70M | -142.19% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 176.83% |
US
|
